tiprankstipranks
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
US Market
IMDX
Insight Molecular Diagnostics
RESEARCH TOOLSreports
Want to see IMDX full AI Analyst Report?

Insight Molecular Diagnostics (IMDX) Financial Statements

432 Followers

Insight Molecular Diagnostics Financial Overview

Insight Molecular Diagnostics's market cap is currently $120.95M. The company's EPS TTM is $-0.72; its P/E ratio is -2.49; Insight Molecular Diagnostics is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Mar 23Dec 21
Income Statement
Total Revenue$ 4.05M$ 1.88M$ 1.50M$ 958.00K$ 2.20M
Gross Profit$ 190.00K$ 740.00K$ 413.00K$ -18.00K$ 1.42M
Operating Income$ -30.58M$ -61.04M$ -25.14M$ -18.00M$ -53.73M
EBITDA$ -28.38M$ -59.02M$ -23.12M$ -13.31M$ -48.46M
Net Income$ -50.22M$ -60.66M$ -27.78M$ -72.90M$ -64.10M
Balance Sheet
Cash & Short-Term Investments$ 11.58M$ 8.64M$ 9.43M$ 20.43M$ 33.85M
Total Assets$ 25.76M$ 35.08M$ 74.89M$ 100.09M$ 159.56M
Total Debt$ 3.50M$ 3.66M$ 2.87M$ 3.54M$ 5.68M
Net Debt$ -8.09M$ -4.97M$ -6.56M$ -16.45M$ -27.27M
Total Liabilities$ 57.22M$ 47.35M$ 54.42M$ 60.50M$ 94.35M
Stockholders' Equity$ -31.46M$ -12.27M$ 20.47M$ 39.59M$ 65.22M
Cash Flow
Free Cash Flow$ -25.37M$ -21.23M$ -23.61M$ -49.91M$ -38.19M
Operating Cash Flow$ -22.18M$ -20.71M$ -23.32M$ -45.57M$ -35.94M
Investing Cash Flow$ -3.19M$ -512.00K$ -932.00K$ -4.34M$ -13.96M
Financing Cash Flow$ 28.07M$ 20.43M$ 12.19M$ 35.81M$ 78.36M
Currency in USD

Insight Molecular Diagnostics Earnings and Revenue History

Income Statement >

Insight Molecular Diagnostics Debt to Assets

Balance Sheet >

Insight Molecular Diagnostics Cash Flow

Cash Flow >

Insight Molecular Diagnostics Forecast EPS vs Actual EPS

Earnings >